<i>NPY</i> Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer - Concepedia

Concepedia

Publication | Closed Access

<i>NPY</i> Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer

15

Citations

35

References

2023

Year

Katleen Janssens, Greetje Vanhoutte, Willem Lybaert, Wim Demey, Jochen Decaestecker, Koen Hendrickx, Hassan Rezaei Kalantari, Karen Zwaenepoel, Patrick Pauwels, Erik Fransén,

Clinical Cancer Research

Abstract

The results of this study confirm that baseline methylated ctDNA is a prognostic marker and indicate that NPY methylation is a promising marker for response monitoring in patients with mCRC.

References

	Year	Citations

Page 1